Menu Search
Equities

Primary Health Properties PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PHP:LSE

Primary Health Properties PLC

Actions
Real EstateReal Estate Investment Trusts
  • Price (GBX)107.90
  • Today's Change2.70 / 2.57%
  • Shares traded10.35m
  • 1 Year change+19.82%
  • Beta0.9706
Data delayed at least 15 minutes, as of Feb 13 2026 14:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 12-Feb-26
Select bar for recommendation details.
Recommendations12-Feb-26
Buy4
Outperform5
Hold1
Sell0
Strong Sell0

Share price forecast in GBX

The 9 analysts offering 12 month price targets for Primary Health Properties PLC have a median target of 115.00, with a high estimate of 128.00 and a low estimate of 105.00. The median estimate represents a 6.58% increase from the last price of 107.90.
High18.6%128.00
Med6.6%115.00
Low-2.7%105.00

Dividends in GBX

In 2024, Primary Health Properties PLC reported a dividend of 0.06 GBP, which represents a 1.99% increase over last year. The 9 analysts covering the company expect dividends of 0.07 GBP for the upcoming fiscal year, an increase of 23.69%.
Note: The percentage change is calculated using unrounded (raw) dividend values.
Div growth (TTM)1.99%
More ▼

Earnings history & estimates in GBX

Primary Health Properties PLC reported annual 2024 earnings of 6.70 per share on Feb 28, 2025.
Average growth rate+4.14%
More ▼

Revenue history & estimates in GBP

Primary Health Properties PLC had revenues for the full year 2024 of 181.70m. This was 7.01% above the prior year's results.
Average growth rate+6.95%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.